Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation
Patriarca, F.; Gaidano, G.; Capello, D.; Zaja, F.; Fanin, R.; Baccarani, M.
Haematologica 85(9): 982-985
2000
ISSN/ISBN: 0390-6078 PMID: 10980639 Document Number: 513224
Background and Objectives: The occurrence of chronic lymphocyte leukemia (CLL) and multiple myeloma (MM) in a single individual is rare and there is no consensus about the clonal relationship of the two disorders and no clinical data about the response to therapy. Design and Methods: We describe a 49-year old patient who developed a stage III IgD kappa MM after fludarabine treatment for a previous diagnosis of CLL and was then submitted to high-dose treatment with autologous CD34+ selected stem cell support. Immunologic and molecular characterizations of peripheral blood and bone marrow were performed at the time of appearance of the two coexisting neoplasms. Results: By immunophenotyping, monoclonal B-lymphocytes stained with lambda chains, whereas marrow plasma cells were positive for kappa chains. The Ig heavy chain rearrangement analysis performed on the bone marrow confirmed the presence of two distinct tumor clones, one of which was also present in the peripheral blood. During 18 months of follow-up after autotransplantation, the CLL-related clone became undetectable, whereas MM persisted with a minimal amount of Bence-Jones proteinuria and 15-20% plasma cell marrow infiltration. Interpretation and Conclusions: Our results suggest that in this patient CLL and MM originated from separate B-cell progenitors. Both disorders were responsive to a CD34+ selected ASCT.